Signal from the log
Pilgrim
25 M$ · Early stage · United States · Diagnostics
Pilgrim fabrique Argus, un appareil qui prélève l'air et séquence son ADN pour détecter des agents biologiques comme Ebola ou l'anthrax, dans le cadre d'un accord de biosurveillance avec le CDC.
Spotted
Announced on , logged by the watch of 23 September 2026.
- Operation
- Funding round
- Announced amount
- 25 M$
- Stage
- Early stage
- Country
- United States
- Sector
- Diagnostics
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
The investors
Led by Buckley Ventures
Provenance
Source linkedin
Logged on 23 September 2026
Description Written in French during the watch run. Based on the headline as relayed by the source, without reading the issuer's press release.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.